Source: PR-INSIDE.COM

Press Release: NeurAxon : NeurAxon, Inc. - Product Pipeline Review - 2014 By Radiant Insights

(PR-inside.com) NeurAxon, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'NeurAxon, Inc. - Product Pipeline Review - 2014', (http://www.radiantinsights.com/research/neuraxon-inc-product-pipeline-review-2014) provides an overview of the NeurAxon, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NeurAxon, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy ..

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
John S. Andrews's photo - President of NeurAxon

President

John S. Andrews

CEO Approval Rating

67/100

Read more